12 Matching Annotations
  1. Last 7 days
  2. www.biorxiv.org www.biorxiv.org
    CDH3 as a Novel Therapeutic Target in Basal-like Double-Negative Prostate Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2025.11.18.689150v1
  3. Oct 2025
  4. www.sciencedirect.com www.sciencedirect.com
    A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunity
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379125004823
  5. May 2025
  6. pubs.acs.org pubs.acs.org
    Polymer-Based DNA Delivery Nanoplatforms for Chimeric Antigen Receptor T Cells Engineering
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pubs.acs.org/doi/full/10.1021/acs.biomac.5c00208
  7. Mar 2025
  8. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Single-cell analysis of neoplastic plasma cells identifies myeloma pathobiology mediators and potential targets
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11866523/
  9. Sep 2024
  10. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Combined assembloid modeling and 3D whole-organ mapping captures the microanatomy and function of the human fallopian tube
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11430475/
  11. Aug 2024
  12. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Development of a highly sensitive platform for protein–protein interaction detection and regulation of T cell function
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11331103/
  13. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10914482/
  14. Jun 2024
  15. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11109160/
  16. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11112799/
  17. Feb 2024
  18. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Engineering self-propelled tumor-infiltrating CAR T cells using synthetic velocity receptors
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10760159/
  19. Jan 2024
  20. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    The CUL5 E3 ligase complex negatively regulates central signaling pathways in CD8+ T cells
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10798966/
  21. link.springer.com link.springer.com
    Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    link.springer.com/article/10.1038/s41467-024-44786-2